SPX3,693.23-64.76 -1.72%
DIA295.86-4.66 -1.55%
IXIC10,867.93-198.88 -1.80%

BRIEF-Luye Pharma Says LY03015 Got Approval From U.S. FDA To Initiate Clinical Trials

BRIEF-Luye Pharma Says LY03015 Got Approval From U.S. FDA To Initiate Clinical Trials

Reuters · 09/13/2022 10:04
BRIEF-Luye Pharma Says LY03015 Got Approval From U.S. FDA To Initiate Clinical Trials

- Luye Pharma Group Ltd 2186.HK:

  • CENTRAL NERVOUS SYSTEM DRUG LY03015 GOT APPROVAL FROM U.S. FDA TO INITIATE CLINICAL TRIALS

Further company coverage: 2186.HK


((Reuters.Briefs@thomsonreuters.com;))